Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Vitravene (Fomivirsen Sodium Intravitreal Injectable) Injection
Company:  Isis Pharmaceuticals, Inc.
Application No.:  20-961
Approval Date: 8/26/1998


Date created: April 10, 2002

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.